Search for: "ANCHEN Pharmaceuticals, Inc."
Results 1 - 20
of 25
Sorted by Relevance
|
Sort by Date
19 Mar 2010, 8:49 am
Plaintiffs argued that jurisdiction was proper because the Delaware contacts of Anchen Inc. should be attributed to Anchen Pharmaceuticals under agency theory. [read post]
27 Sep 2009, 9:25 pm
Anchen Pharmaceuticals Inc. et al. 1:09-cv-00715; filed September 23, 2009 in the District Court of Delaware • Plaintiffs: Eurand Inc.; Anesta AG • Defendants: Anchen Pharmaceuticals Inc.; Anchen Inc. [read post]
6 Jun 2010, 8:45 pm
Hunt MD • Defendants: Anchen Pharmaceuticals Inc.; Anchen Inc. [read post]
16 Jan 2011, 9:17 pm
Anchen Pharmaceuticals Inc. et al. 1:11-cv-00046; filed January 12, 2011 in the District Court of Delaware • Plaintiff: GlaxoSmithKline LLC • Defendants: Anchen Pharmaceuticals Inc.; Anchen Inc.; Banner Pharmacaps Inc. [read post]
12 May 2014, 9:18 am
Anchen Pharmaceuticals, Inc., et al., C.A. [read post]
4 Nov 2011, 12:26 pm
Anchen Pharmaceuticals, Inc., C.A. [read post]
16 Nov 2012, 11:58 am
Anchen Pharmaceuticals, Inc., et al., C.A. [read post]
9 Oct 2009, 9:11 am
Anchen Pharmaceuticals Inc. and Anchen Inc. [read post]
18 Dec 2009, 9:59 am
Anchen Pharmaceuticals and Anchen Inc. [read post]
23 Jun 2010, 10:28 pm
Anchen Pharmaceuticals, Inc. [read post]
6 Oct 2010, 4:22 am
Sandoz, Inc. et al (Docket Report) [read post]
10 Jun 2010, 3:58 am
Anchen Pharmaceuticals Inc. et al. [read post]
10 Feb 2010, 4:47 pm
Anchen Pharmaceuticals Inc. [read post]
2 Sep 2009, 5:57 pm
: Jacobson v Celgene (Patent Baristas) Ultracet (Tramadol/Acetaminophen) – US: CAFC vacates Ultracet obviousness decision: Ortho-McNeil Pharmaceutical, Inc v Teva Pharmaceuticals (not precedential) (Patently-O) (Patent Docs) (SmartBrief) Viread (Tenofovir) – India: MSF announces Patent Office rejected patents on AIDS drugs Tenofovir and Darunavir (Intellectual Property Watch) [read post]
6 Apr 2011, 12:18 am
427/09 Generics (UK) Ltd v Synaptech Inc (The SPC Blog) Simcor (Niacin, Simvastatin) – US: Abbott files patent infringement complaint against Watson following Para IV certification filing (Patent Docs) Thalomid (Thalidomide) – US: Decision in Lannett Thalomid bioequivalence study sample antitrust lawsuit could reignite debate on generic drug availability and REMS restrictions (FDA Law Blog) Yasmin (Drospirenone, Ethinylestradiol) – UK: Bayer Yasmin patents survive patent… [read post]
8 Oct 2009, 6:05 am
Teva Pharmaceuticals USA, Inc (Patent Docs) (Patent Baristas) (GenericsWeb) General Biotech legislative agenda: healthcare, energy, patents and capital (IP Watch) India: Applying for patents does pay: Wockhardt wins kudos from the Indian government (SPICY IP) US: CAFC ruling in Board of Trustees of the Leland Stanford Junior University et al v Roche Molecular Systems et al - How to lose a patent? [read post]
27 May 2010, 3:20 am
Anchen Pharmaceuticals Inc et al. [read post]
14 Jun 2010, 1:07 pm
That case involved Bupropion HCl Extended-Release Tablets, 300 mg, and a single first applicant – Anchen Pharmaceuticals, Inc. [read post]
3 Nov 2010, 1:21 am
No – discussion of patent-eligibility standards for genes (Patent Baristas) US: Appellees file reply brief in Therasense v Becton Dickinson (Patent Docs) US: Another Capitol Hill missive objects to the inclusion of patent settlement provisions in FY 2011 Appropriations Bill (FDA Law Blog) US: REMS and 180-day exclusivity forfeiture – some interesting disclosures to the SEC (FDA Law Blog) Products Botox (Botulinum) – EU: General Court upholds opposition to BOTUMAX Community… [read post]
22 Apr 2010, 3:51 am
Paddock Laboratories, Inc. [read post]
